
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 12, 2025, titled "Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 12, 2025, titled "Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals